Effect of growth factors on proliferation and phenotypic differentiation of human fetal neural stem cells

Yevgeniya I. Tarasenko, Yongjia Yu, Paivi M. Jordan, Jane Bottenstein, Ping Wu

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Human fetal neural stem cells (hNSCs) can be expanded in vitro by mitogens or growth factors, such as basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and/or leukemia inhibitory factor (LIF). Their effects on proliferation rate and differentiation pattern of hNSCs, however, have not been fully characterized. In this study, we cultured hNSCs in seven regimens, including bGF, EGF, and LlF, either alone or in combinations. Cells were maintained as neurospheres in treatment media for various periods, up to six passages. A combination of bFGF, EGF, and LIF expanded hNSCs more efficiently than any other treatment as determined by counting total cell numbers using a trypan blue exclusion assay, a WST-1 cell viability assay, and a bromodeoxyuridine incorporation flow cytometric analysis. Differentiation patterns of hNSCs expanded under different conditions were also analyzed. We reported previously that hNSCs primed in vitro with a combination of bFGF, heparin, and laminin (FHL) induced neuronal differentiation toward a cholinergic phenotype. In this study, we show that the FHL priming increases neuronal differentiation while decreasing astroglial generation in all treatment groups as determined by immunostaining. However, cells proliferated under different growth factor conditions do vary in their Particularly, significant generation of cholinergic cells was observed only in hNSCs expanded with EGF/ bFGF or EGF/bFGF/LIF, but not with other treatment regimens, even when they are exposed to the same priming procedure. Our results indicate that hNSCs are highly plastic, with their proliferation and differentiation potential dependent on different growth factor treatments.

Original languageEnglish (US)
Pages (from-to)625-636
Number of pages12
JournalJournal of Neuroscience Research
Volume78
Issue number5
DOIs
StatePublished - Dec 1 2004

Fingerprint

Fetal Stem Cells
Neural Stem Cells
Intercellular Signaling Peptides and Proteins
Fibroblast Growth Factor 2
Epidermal Growth Factor
Leukemia Inhibitory Factor
Cholinergic Agents
Trypan Blue
Laminin
Bromodeoxyuridine
Mitogens
Plastics
Heparin
Cell Survival
Cell Count
Phenotype

Keywords

  • Cell differentiation
  • Cholinergic phenotype
  • Epidermal growth factor
  • Fibroblast growth factor
  • Heparin
  • Human neural stem cells
  • Leukemia inhibitory factor
  • Mitogens

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Effect of growth factors on proliferation and phenotypic differentiation of human fetal neural stem cells. / Tarasenko, Yevgeniya I.; Yu, Yongjia; Jordan, Paivi M.; Bottenstein, Jane; Wu, Ping.

In: Journal of Neuroscience Research, Vol. 78, No. 5, 01.12.2004, p. 625-636.

Research output: Contribution to journalArticle

Tarasenko, Yevgeniya I. ; Yu, Yongjia ; Jordan, Paivi M. ; Bottenstein, Jane ; Wu, Ping. / Effect of growth factors on proliferation and phenotypic differentiation of human fetal neural stem cells. In: Journal of Neuroscience Research. 2004 ; Vol. 78, No. 5. pp. 625-636.
@article{b9deb12688a542e8911e1c087a378cbd,
title = "Effect of growth factors on proliferation and phenotypic differentiation of human fetal neural stem cells",
abstract = "Human fetal neural stem cells (hNSCs) can be expanded in vitro by mitogens or growth factors, such as basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and/or leukemia inhibitory factor (LIF). Their effects on proliferation rate and differentiation pattern of hNSCs, however, have not been fully characterized. In this study, we cultured hNSCs in seven regimens, including bGF, EGF, and LlF, either alone or in combinations. Cells were maintained as neurospheres in treatment media for various periods, up to six passages. A combination of bFGF, EGF, and LIF expanded hNSCs more efficiently than any other treatment as determined by counting total cell numbers using a trypan blue exclusion assay, a WST-1 cell viability assay, and a bromodeoxyuridine incorporation flow cytometric analysis. Differentiation patterns of hNSCs expanded under different conditions were also analyzed. We reported previously that hNSCs primed in vitro with a combination of bFGF, heparin, and laminin (FHL) induced neuronal differentiation toward a cholinergic phenotype. In this study, we show that the FHL priming increases neuronal differentiation while decreasing astroglial generation in all treatment groups as determined by immunostaining. However, cells proliferated under different growth factor conditions do vary in their Particularly, significant generation of cholinergic cells was observed only in hNSCs expanded with EGF/ bFGF or EGF/bFGF/LIF, but not with other treatment regimens, even when they are exposed to the same priming procedure. Our results indicate that hNSCs are highly plastic, with their proliferation and differentiation potential dependent on different growth factor treatments.",
keywords = "Cell differentiation, Cholinergic phenotype, Epidermal growth factor, Fibroblast growth factor, Heparin, Human neural stem cells, Leukemia inhibitory factor, Mitogens",
author = "Tarasenko, {Yevgeniya I.} and Yongjia Yu and Jordan, {Paivi M.} and Jane Bottenstein and Ping Wu",
year = "2004",
month = "12",
day = "1",
doi = "10.1002/jnr.20316",
language = "English (US)",
volume = "78",
pages = "625--636",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Effect of growth factors on proliferation and phenotypic differentiation of human fetal neural stem cells

AU - Tarasenko, Yevgeniya I.

AU - Yu, Yongjia

AU - Jordan, Paivi M.

AU - Bottenstein, Jane

AU - Wu, Ping

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Human fetal neural stem cells (hNSCs) can be expanded in vitro by mitogens or growth factors, such as basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and/or leukemia inhibitory factor (LIF). Their effects on proliferation rate and differentiation pattern of hNSCs, however, have not been fully characterized. In this study, we cultured hNSCs in seven regimens, including bGF, EGF, and LlF, either alone or in combinations. Cells were maintained as neurospheres in treatment media for various periods, up to six passages. A combination of bFGF, EGF, and LIF expanded hNSCs more efficiently than any other treatment as determined by counting total cell numbers using a trypan blue exclusion assay, a WST-1 cell viability assay, and a bromodeoxyuridine incorporation flow cytometric analysis. Differentiation patterns of hNSCs expanded under different conditions were also analyzed. We reported previously that hNSCs primed in vitro with a combination of bFGF, heparin, and laminin (FHL) induced neuronal differentiation toward a cholinergic phenotype. In this study, we show that the FHL priming increases neuronal differentiation while decreasing astroglial generation in all treatment groups as determined by immunostaining. However, cells proliferated under different growth factor conditions do vary in their Particularly, significant generation of cholinergic cells was observed only in hNSCs expanded with EGF/ bFGF or EGF/bFGF/LIF, but not with other treatment regimens, even when they are exposed to the same priming procedure. Our results indicate that hNSCs are highly plastic, with their proliferation and differentiation potential dependent on different growth factor treatments.

AB - Human fetal neural stem cells (hNSCs) can be expanded in vitro by mitogens or growth factors, such as basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and/or leukemia inhibitory factor (LIF). Their effects on proliferation rate and differentiation pattern of hNSCs, however, have not been fully characterized. In this study, we cultured hNSCs in seven regimens, including bGF, EGF, and LlF, either alone or in combinations. Cells were maintained as neurospheres in treatment media for various periods, up to six passages. A combination of bFGF, EGF, and LIF expanded hNSCs more efficiently than any other treatment as determined by counting total cell numbers using a trypan blue exclusion assay, a WST-1 cell viability assay, and a bromodeoxyuridine incorporation flow cytometric analysis. Differentiation patterns of hNSCs expanded under different conditions were also analyzed. We reported previously that hNSCs primed in vitro with a combination of bFGF, heparin, and laminin (FHL) induced neuronal differentiation toward a cholinergic phenotype. In this study, we show that the FHL priming increases neuronal differentiation while decreasing astroglial generation in all treatment groups as determined by immunostaining. However, cells proliferated under different growth factor conditions do vary in their Particularly, significant generation of cholinergic cells was observed only in hNSCs expanded with EGF/ bFGF or EGF/bFGF/LIF, but not with other treatment regimens, even when they are exposed to the same priming procedure. Our results indicate that hNSCs are highly plastic, with their proliferation and differentiation potential dependent on different growth factor treatments.

KW - Cell differentiation

KW - Cholinergic phenotype

KW - Epidermal growth factor

KW - Fibroblast growth factor

KW - Heparin

KW - Human neural stem cells

KW - Leukemia inhibitory factor

KW - Mitogens

UR - http://www.scopus.com/inward/record.url?scp=10644239032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10644239032&partnerID=8YFLogxK

U2 - 10.1002/jnr.20316

DO - 10.1002/jnr.20316

M3 - Article

VL - 78

SP - 625

EP - 636

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 5

ER -